Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Lymphoid 2Sarcoma 1

Conditions

Breast Neoplasms 4Neoplasms 3Anxiety Disorders 3Motor Activity 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Weight Gain 1Vomiting 1Triple Negative Breast Neoplasms 1Treatment Adherence and Compliance 1Sclerosteosis 1Recurrence 1Periodontitis 1Periodontal Diseases 1Patient Compliance 1Osteoporosis, Postmenopausal 1Obesity 1Nausea 1Lymphedema 1Liver Cirrhosis 1Leukemia, Promyelocytic, Acute 1Inflammation 1Gastrointestinal Neoplasms 1Feeding Behavior 1Dendritic Cell Sarcoma, Interdigitating 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Rituximab 416Cyclophosphamide 348Vincristine 173Prednisone 172Doxorubicin 168Etoposide 160Peripheral Blood Stem Cell Transplantation 114Filgrastim 108Lenalidomide 97fludarabine phosphate 96Radiotherapy 80Cytarabine 80Gemcitabine 73Melphalan 66Mycophenolic Acid 64Cyclosporine 60Methotrexate 59Busulfan 57Ifosfamide 55Carmustine 55fludarabine 50Tacrolimus 50Whole-Body Irradiation 49Carboplatin 49polatuzumab vedotin 44Oxaliplatin 44Dexamethasone 44Antilymphocyte Serum 42ibrutinib 40Bendamustine Hydrochloride 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Lymphoma, Large B-Cell, Diffuse × Weights and Measures × Clear all
NCT04319237 2026-03-02

Axicabtagene Ciloleucel:Neurocognitive and Patient-Reported Outcomes

H. Lee Moffitt Cancer Center and Research Institute

Completed
60 enrolled
Lymphoid

Lymphoma, Large B-Cell, Diffuse

NCT04113226 2023-02-08

Relyage

Centre Hospitalier Universitaire, Amiens

Phase 2 Unknown
114 enrolled
LymphoidSarcoma

Recurrence, Lymphoma, Large B-Cell, Diffuse, Dendritic Cell Sarcoma, Interdigitating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡